Literature DB >> 7429293

Blood methanethiol in alcoholic liver disease with and without hepatic encephalopathy.

C J McClain, L Zieve, W M Doizaki, S Gilberstadt, G R Onstad.   

Abstract

Blood methanethiol and ammonia concentrations were measured in 16 healty volunteers, 52 consecutive alcoholic cirrhotics without overt hepatic encephalopathy (HE), and 42 consecutive patients with alcoholic liver disease and overt HE. The mean concentration of blood methanethiol was significantly greater than normal in the cirrhotics without overt HE, and the means of both methanethiol and ammonia were significantly greater in the patients with than in those without overt HE. Only one patient with overt HE had both normal ammonia and methanethiol blood concentrations. Twenty of the patients with HE were followed serially. The directions of change in methanethiol and ammonia were consistent with the direction of change in mental status in 85% adn 60% respectively. All of the patients who deteriorated and died had changes in blood methanethiol that correlated with the change in mental status. We conclude that blood methanethiol is a valuable adjunct to the ammonia determination in the evaluation of the patient with possible HE. It is especially helpful in following the course of a patient with hepatic encephalopathy, both as to prognosis and as an indicator of response to therapy.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7429293      PMCID: PMC1419608          DOI: 10.1136/gut.21.4.318

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  11 in total

1.  Methyl mercaptan in relation to foetor hepaticus.

Authors:  F CHALLENGER; J M WALSHE
Journal:  Biochem J       Date:  1955-03       Impact factor: 3.857

2.  Formation of artifactual ammonia in blood by action of alkali. Its significance for the measurement of blood ammonia.

Authors:  J G REINHOLD; C C CHUNG
Journal:  Clin Chem       Date:  1961-02       Impact factor: 8.327

3.  Methionine toxicity in liver disease and its prevention by chlortetracycline.

Authors:  E A PHEAR; B RUEBNER; S SHERLOCK; W H SUMMERSKILL
Journal:  Clin Sci       Date:  1956-02       Impact factor: 6.124

4.  The electroencephalograph in liver disease.

Authors:  B G PARSONS-SMITH; W H SUMMERSKILL; A M DAWSON; S SHERLOCK
Journal:  Lancet       Date:  1957-11-02       Impact factor: 79.321

5.  Action of methanethiol on membrane (Na+ , K+)-ATPase of rat brain.

Authors:  G Quarfoth; H Ahmed; D Foster; L Zieve
Journal:  Biochem Pharmacol       Date:  1976-05-01       Impact factor: 5.858

6.  Studies in methionine metabolism; fasting plasma methionine levels in normal and hepatopathic individuals in response to daily methionine ingestion.

Authors:  L W KINSELL; H A HARPER
Journal:  J Clin Invest       Date:  1949-11       Impact factor: 14.808

7.  An improved method for measuring blood mercaptans.

Authors:  W M Doizaki; L Zieve
Journal:  J Lab Clin Med       Date:  1977-11

8.  Synergism between mercaptans and ammonia or fatty acids in the production of coma: a possible role for mercaptans in the pathogenesis of hepatic coma.

Authors:  L Zieve; W M Doizaki; J Zieve
Journal:  J Lab Clin Med       Date:  1974-01

9.  Mercaptans and dimethyl sulfide in the breath of patients with cirrhosis of the liver. Effect of feeding methionine.

Authors:  S Chen; L Zieve; V Mahadevan
Journal:  J Lab Clin Med       Date:  1970-04

10.  Methionine-induced hepatic coma in dogs.

Authors:  G E Merino; T Jetzer; W M Doizaki; J S Najarian
Journal:  Am J Surg       Date:  1975-07       Impact factor: 2.565

View more
  8 in total

Review 1.  Pathogenesis of hepatic encephalopathy in cirrhosis: the concept of synergism revisited.

Authors:  Roger F Butterworth
Journal:  Metab Brain Dis       Date:  2015-11-02       Impact factor: 3.584

Review 2.  Interrelationships of liver and brain with special reference to Reye syndrome.

Authors:  J K Brown; H Imam
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

3.  Current concepts in the pathophysiology and management of hepatic encephalopathy.

Authors:  R Todd Frederick
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-04

Review 4.  Pathogenesis of hepatic encephalopathy.

Authors:  L Zieve
Journal:  Metab Brain Dis       Date:  1987-09       Impact factor: 3.584

5.  Effect of dietary protein manipulation in subclinical portal-systemic encephalopathy.

Authors:  K M de Bruijn; L M Blendis; D H Zilm; P L Carlen; G H Anderson
Journal:  Gut       Date:  1983-01       Impact factor: 23.059

6.  Blood and brain concentrations of mercaptans in hepatic and methanethiol induced coma.

Authors:  H Al Mardini; K Bartlett; C O Record
Journal:  Gut       Date:  1984-03       Impact factor: 23.059

7.  Impaired metabolism of methionine in severe liver diseases. II. Clinical and experimental studies on role of impaired methionine metabolism in pathogenesis of hepatic encephalopathy.

Authors:  T Higashi
Journal:  Gastroenterol Jpn       Date:  1982-04

Review 8.  Hepatic encephalopathy: early diagnosis in pediatric patients with cirrhosis.

Authors:  Naghi Dara; Ali-Akbar Sayyari; Farid Imanzadeh
Journal:  Iran J Child Neurol       Date:  2014
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.